Gastric antral vascular ectasia unmasked by alprostadil for digital ulceration in scleroderma

Journal of Rheumatology

Volumn 38, Issue 4, 2011, Pages 784-785

  Omair, Mohammed A ^a   Johnson, Sindhu R ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; GLYCERYL TRINITRATE; HEMOGLOBIN; LOSARTAN; NIFEDIPINE; PANTOPRAZOLE; PENTOXIFYLLINE; PROSTAGLANDIN E1;

ADULT; CASE REPORT; CLINICAL FEATURE; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG TREATMENT FAILURE; ERYTHROCYTE TRANSFUSION; ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS ULCER; FEMALE; HAND DISEASE; HUMAN; LETTER; LIMITED SCLERODERMA; PRIORITY JOURNAL; SIDE EFFECT; SKIN ULCER; STOMACH ANTRUM VASCULAR ECTASIA; TREATMENT DURATION; VOMITING;

ALPROSTADIL; FEMALE; GASTRIC ANTRAL VASCULAR ECTASIA; HUMANS; MIDDLE AGED; PROSTAGLANDINS; SCLERODERMA, LIMITED; VASODILATOR AGENTS;

EID: 79953326127     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.101173     Document Type: Letter

References (10)

1. Kowal-Bielecka O, Landewe R, Avouac J, Chwiesko S, Miniati I, Czirjak L, et al. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 2009;68:620-8.
2. Jones DA, Benjamin CW, Linseman DA. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades. Mol Pharmacol 1995;48:890-6.
3. Boyer-Neumann C, Brenot F, Wolf M, Peynaud-Debayle E, Duroux P, Meyer D, et al. Continuous infusion of prostacyclin decreases plasma levels of t-PA and PAI-1 in primary pulmonary hypertension. Thromb Haemost 1995;73:735-6.
4. Friedman R, Mears JG, Barst RJ. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension. Circulation 1997;96:2782-4. (Pubitemid 27500070)
5. Forbes A, Marie I. Gastrointestinal complications: the most frequent internal complications of systemic sclerosis. Rheumatology 2009;48 Suppl 3:iii36-9.
6. Duchini A, Sessoms SL. Gastrointestinal hemorrhage in patients with systemic sclerosis and CREST syndrome. Am J Gastroenterol 1998;93:1453-6. (Pubitemid 29075181)
7. Ingraham KM, O'Brien MS, Shenin M, Derk CT, Steen VD. Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors. J Rheumatol;37:603-7.
8. Marie I, Ducrotte P, Antonietti M, Herve S, Levesque H. Watermelon stomach in systemic sclerosis: its incidence and management. Aliment Pharmacol Ther 2008;28:412-21. (Pubitemid 352033274)
9. Jabbari M, Cherry R, Lough JO, Daly DS, Kinnear DG, Goresky CA. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology 1984;87:1165-70. (Pubitemid 14017088)
10. Watson M, Hally RJ, McCue PA, Varga J, Jimenez SA. Gastric antral vascular ectasia (watermelon stomach) in patients with systemic sclerosis. Arthritis Rheum 1996;39:341-6. (Pubitemid 26065278)